Unimax Group

Unimax Group is a research-driven pharmaceutical conglomerate based in India, specializing in the development, manufacturing, and global distribution of Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical formulations. Established in 1970, the group operates through key subsidiaries such as Unimax Chemicals and Unimax Laboratories, maintaining WHO-GMP certified facilities. Its extensive product portfolio spans diverse therapeutic areas, including antibiotics, anti-diabetics, cardiovascular health, and nutritional supplements. The company is particularly recognized for its expertise in erythromycin-based antibiotics and provides integrated services ranging from R&D and regulatory compliance to contract manufacturing for international markets across Asia, Latin America, and Africa.